IP Library › Granted Patent US 12,442,628
Granted Patent B2
US 12,442,628 · App. 18/381,506 · Granted Oct 14, 2025

Multifunctional composite projectiles and methods of manufacturing the same

Inventors: Robert Folaron (Colorado Springs, CO); Howard D. Kent (Waldport, OR); Jennifer Folaron (Colorado Springs, CO)
Assignee: Smart Nanos, LLC
F42B12/367F42B12/72
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,442,628
App. No.
18/381,506
Granted
Oct 14, 2025
Kind
B2
Abstract

Composite projectiles include various material compositions, diameters, and cavities within the projectiles having a variety of cavity diameters, sidewalls, and bottoms selected and formed to induce different levels of penetration and disintegration of the composite projectiles upon impact with targets.

Claims (9)

1. A molded frangible composite projectile, comprising:

a leading end;

a trailing end, the leading and trailing ends being monolithically molded from a mixture including 85-95% metallic particles and less than 10% of a polymer;

a projectile diameter; and

a cavity formed within the composite projectile, the cavity defining a cavity opening, a cavity depth, a cavity diameter, a cavity sidewall, and a cavity bottom and being configured to induce pressure within the cavity and disintegration of the composite projectile upon impact with a target, the cavity opening being at least concentric with the cavity sidewall.

2. The molded frangible composite projectile as in claim 1 , wherein the projectile diameter and the cavity diameter define a ratio to induce pressure and dictate a depth of penetration of the target.

3. The molded frangible composite projectile as in claim 1 , wherein the cavity depth and cavity diameter define an aspect ratio dictating a depth of penetration of the target.

4. The molded frangible composite projectile as in claim 1 , wherein the cavity sidewall is formed at an angle in a direction away from the cavity opening and towards the cavity bottom such that the cavity opening is larger than the cavity bottom, the angle contributing to the pressure within the cavity to dictate a rate of expansion.

5. The molded frangible composite projectile as in claim 1 , wherein the cavity bottom defines a shape configured to dictate degrees of disintegration of the composite projectile.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2023
From: FOLARON, ROBERT; KENT, HOWARD D.; FOLARON, JENNIFER
To: SMART NANOS, LLC
Reel/Frame 065271/0761 →
Continuity (4)
Continuation In Part 16936301 · Jul 22, 2020
Continuation In Part 16162179 · Oct 16, 2018
Provisional Application 62573632 · Oct 17, 2017
Related Publication 20240068788A1 · Feb 29, 2024
References Cited (109)
US 1135357A · Clyne · 1915 [cited by applicant]
US 4035116A · O'Brien et al. · 1977 [cited by applicant]
US 4239006A · Kelson · 1980 [cited by applicant]
US 4684161A · Egner et al. · 1987 [cited by applicant]
US 4860661A · Bock et al. · 1989 [cited by applicant]
US 4921250A · Ayres · 1990 [cited by applicant]
US 4961778A · Pyzik et al. · 1990 [cited by applicant]
US 5035183A · Luxton · 1991 [cited by applicant]
US 5164538A · McClain, II · 1992 [cited by applicant]
US 5237930A · Belanger et al. · 1993 [cited by applicant]
US 5616642A · West et al. · 1997 [cited by applicant]
US 5679920A · Hallis et al. · 1997 [cited by applicant]
US 5760331A · Lowden et al. · 1998 [cited by applicant]
US 5763819A · Huffman · 1998 [cited by applicant]
US 5814759A · Mravic et al. · 1998 [cited by applicant]
US 5852255A · Hallis et al. · 1998 [cited by applicant]
US 5852858A · Hallis et al. · 1998 [cited by applicant]
US 5894645A · Hallis et al. · 1999 [cited by applicant]
US 5917143A · Stone · 1999 [cited by applicant]
US 6074454A · Abrams et al. · 2000 [cited by applicant]
US 6090178A · Benini · 2000 [cited by applicant]
US 6115894A · Huffman · 2000 [cited by applicant]
US 6145441A · Woodall et al. · 2000 [cited by applicant]
US 6257147B1 · Davies · 2001 [cited by applicant]
US 6257149B1 · Cesaroni · 2001 [cited by applicant]
US 6263798B1 · Benini · 2001 [cited by applicant]
US 6536352B1 · Nadkarni et al. · 2003 [cited by applicant]
US 6649095B2 · Buja · 2003 [cited by applicant]
US 6691623B1 · Stone · 2004 [cited by applicant]
US 6694888B2 · Jopson et al. · 2004 [cited by applicant]
US 6740260B2 · McCord · 2004 [cited by applicant]
US 6776101B1 · Pickard · 2004 [cited by examiner]
US 6799518B1 · Williams · 2004 [cited by applicant]
US 7143679B2 · Yaich · 2006 [cited by applicant]
US 7322297B2 · Yaich · 2008 [cited by applicant]
US 7380503B2 · Williams et al. · 2008 [cited by applicant]
US 7555987B2 · Powers, Jr. · 2009 [cited by applicant]
US 7654202B2 · Romero · 2010 [cited by applicant]
US 7658137B1 · Romero · 2010 [cited by applicant]
US 7685942B1 · Powers, Jr. · 2010 [cited by applicant]
US 7966937B1 · Jackson · 2011 [cited by examiner]
US 7992500B2 · Williams · 2011 [cited by applicant]
US 8028026B2 · Jain et al. · 2011 [cited by applicant]
US 8028626B2 · Hash et al. · 2011 [cited by applicant]
US 8186277B1 · King · 2012 [cited by examiner]
US 8225718B2 · Joys et al. · 2012 [cited by applicant]
US 8308986B1 · Stuart · 2012 [cited by applicant]
US 8312815B1 · Joys et al. · 2012 [cited by applicant]
US 8347788B1 · Leasure · 2013 [cited by applicant]
US 8365672B2 · Martinez et al. · 2013 [cited by applicant]
US 8393273B2 · Weeks et al. · 2013 [cited by applicant]
US 8468947B2 · Hash et al. · 2013 [cited by applicant]
US 8833262B2 · Leasure · 2014 [cited by applicant]
US 8881654B2 · Seecamp · 2014 [cited by applicant]
US 8893621B1 · Escobar · 2014 [cited by applicant]
US 8919778B2 · Fodera · 2014 [cited by applicant]
US 8997653B1 · Calvert · 2015 [cited by applicant]
US 9046033B2 · Orthmann · 2015 [cited by applicant]
US 9057591B2 · Hash et al. · 2015 [cited by applicant]
US 9157713B1 · Peterson et al. · 2015 [cited by applicant]
US 9170080B2 · Poore et al. · 2015 [cited by applicant]
US 9188416B1 · Hash et al. · 2015 [cited by applicant]
US 9194680B2 · Padgett et al. · 2015 [cited by applicant]
US 9227353B2 · Williams · 2016 [cited by applicant]
US 9261335B2 · Padgett · 2016 [cited by applicant]
US 9316468B2 · Rall · 2016 [cited by examiner]
US 9372054B2 · Padgett · 2016 [cited by applicant]
US 9383178B2 · Powers, Jr. · 2016 [cited by applicant]
US 9388090B2 · Joshi et al. · 2016 [cited by applicant]
US 9631910B2 · Fricke · 2017 [cited by examiner]
US 10072914B2 · Flint · 2018 [cited by examiner]
US 10126105B2 · Lemke et al. · 2018 [cited by applicant]
US 10690464B2 · Peterson · 2020 [cited by examiner]
US 10823539B1 · Oberholster · 2020 [cited by examiner]
US 11156442B1 · Kampo et al. · 2021 [cited by applicant]
US 20010050020A1 · Davis et al. · 2001 [cited by applicant]
US 20060144281A1 · Williams et al. · 2006 [cited by applicant]
US 20070095241A1 · Rice et al. · 2007 [cited by applicant]
US 20070151474A1 · Widener · 2007 [cited by applicant]
US 20080035008A1 · Riess et al. · 2008 [cited by applicant]
US 20100212535A1 · Beal · 2010 [cited by applicant]
US 20110252997A1 · Hoffman · 2011 [cited by applicant]
US 20120111220A1 · King · 2012 [cited by examiner]
US 20140318402A1 · Carlson et al. · 2014 [cited by applicant]
US 20150354929A1 · Minnicino, II · 2015 [cited by applicant]
US 20160265889A1 · Golloher et al. · 2016 [cited by applicant]
US 20170089672A1 · Burrow · 2017 [cited by applicant]
US 20170314900A1 · Mahnke · 2017 [cited by applicant]
US 20200240758A1 · Thompson · 2020 [cited by applicant]
DE 10209035A1 · 2003 [cited by applicant]
DE 102015007617A1 · 2016 [cited by applicant]
EP 3470769A1 · 2019 [cited by applicant]
GB 2278423A · 1994 [cited by applicant]
JP 2001516008A1 · 2001 [cited by applicant]
KR 20010025436A · 2001 [cited by applicant]
WO 9738282A1 · 1997 [cited by applicant]
WO 2016007212A2 · 2016 [cited by applicant]
WO 2022241127A1 · 2022 [cited by applicant]
ALARCON; “Adult Blood Lead Epidemiology and Surveillance—United States, 2008-2009”; Morbidity and Weekly Report; Jul. 1, 2011/vol. 60/No. 25; pp. 841-845. [cited by applicant]
Beaucham; “Indoor Firing Ranges and Elevated Blood Lead Levels”; Morbidity and Mortality Weekly Report Apr. 25, 2014, vol. 63, No. 16; pp. 347-351. [cited by applicant]
Final Office Action issued Dec. 23, 2019 in U.S. Appl. No. 16/162,179. [cited by applicant]
International Search Report issued Jan. 8, 2019 in PCT/US18/56151. [cited by applicant]
Non-Final Office Action issued May 3, 2019 is U.S. Appl. No. 16/162,179. [cited by applicant]
Notice of Allowance issued Apr. 22, 2020 in U.S. Appl. No. 16/162,179. [cited by applicant]
United States Environmental Protection Agency; “Best Management Practices for Lead at Outdoor Shooting Ranges” Revised Jun. 2005; Chapter I, pp. 1-1-1-13. [cited by applicant]
Written Opinion of the International Searching Authority issued Jan. 8, 2019 in PCT/U18/56151. [cited by applicant]
Machine Translation of Foreign Reference 1: Abstract of DE 102015007617; Published: Dec. 22, 2016. [cited by applicant]
Machine Translation of Foreign Reference 2: Abstract of DE 10209035; Published: Sep. 18, 2003. [cited by applicant]
Machine Translation of Foreign Reference 3: Abstract of KR 20010025436; Published: Sep. 18, 2003. [cited by applicant]
Cited By (1)
US 12,723,856